Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Cardiology

Living with CAD: Monitoring and Daily Life

At a Glance

Living with coronary atherosclerosis requires individualized follow-up rather than routine testing for everyone. Taking medicines as prescribed, using nitroglycerin safely, joining cardiac rehabilitation, staying active, and addressing anxiety can help lower heart-event risk and support daily life.

Living with coronary atherosclerosis (CAD) is a journey of ongoing management rather than a one-time treatment. While the diagnosis is lifelong, it is highly manageable [1]. By combining modern medical therapy, routine monitoring, and the habits learned in cardiac rehabilitation, most people can lead active, full lives while significantly reducing their risk of future heart events [2][3].

Your Long-Term Surveillance Plan

Current guidelines do not support a “one-size-fits-all” schedule. Follow-up and laboratory timing vary depending on recent medication changes, symptoms, kidney function, diabetes, and whether you recently had an acute event or procedure [1].

  • Routine Visits: As a general example, stable patients typically see their provider every 6 to 12 months for a physical exam and symptom review [1].
  • Laboratory Monitoring: Your care team will regularly check your LDL-C, blood pressure, and HbA1c (if applicable) [4]. Lipid values are often rechecked 4 to 12 weeks after any change in medication [5].
  • The Role of Testing: Routine “surveillance” stress tests or imaging (testing when you have no symptoms just to “check in”) do not typically improve outcomes for stable asymptomatic patients and may lead to unnecessary procedures [6]. However, testing is utilized if you experience new functional decline, worsening symptoms, or selected high-risk situations [7][8].

The Role of Medication Adherence

Taking your medications exactly as prescribed is one of the most powerful predictors of long-term survival [3].

  • Patients who consistently take their prescribed medications have a significantly lower risk of death, heart attack, and hospitalization [3].
  • Good adherence is also linked to better daily quality of life and fewer episodes of chest pain [9].

Using Rescue Nitroglycerin

Nitroglycerin is a “rescue” medication used to treat an episode of angina [10]. Because every product is different, you must follow the specific instructions on your medication’s label and the Angina Action Plan provided by your doctor [11][1].

  • CRITICAL SAFETY WARNING: Nitrates must never be combined with phosphodiesterase-5 inhibitors (such as sildenafil, tadalafil, vardenafil, or avanafil) or with riociguat. This combination can cause potentially dangerous, life-threatening low blood pressure. Always inform EMS about recent use of these medicines.
  • Storage: Storage and expiration instructions vary by tablet versus spray and product label. Generally, tablets should be kept in their original container.
  • When to Call 911: Follow your individual action plan. Do not delay emergency care while repeatedly treating persistent pain. If your symptoms are new, worsening, occurring at rest, or are not relieved exactly as your action plan outlines, call 911 immediately [8][12].

Rebuilding Confidence: Cardiac Rehabilitation

If you have recently had a procedure or a heart event, cardiac rehabilitation (CR) is a critical step in your recovery. CR is a structured program of supervised exercise, education, and support [1]. It can also be appropriate for some people with stable chronic coronary disease.

  • Long-Term Benefits: Completing a CR program is associated with a lower risk of recurrent heart attacks [2]. It significantly improves your functional capacity [13][14].
  • Moving to Independence: Professionally supported home-based or digital rehabilitation can be just as effective as center-based programs for keeping you active [15][16].

Addressing the Psychological Impact: “Heart Anxiety”

It is very common to feel worry or “heart anxiety” after a CAD diagnosis.

  • Approximate estimates indicate that up to 40% of CAD populations experience some level of depression, and many experience anxiety [17][18]. These symptoms are common and highly treatable.
  • Persistent anxiety and depression are linked to a lower quality of life [17][19].
  • Rebuilding your confidence through supervised exercise in cardiac rehab is one of the best ways to overcome the fear of activity [2][15]. Psychological interventions and medication can also help [20][21].
  • Emergency Warning: Seek help immediately if you have thoughts of self-harm.

Living well with CAD means being a partner in your own care. By tracking your symptoms, adhering to your medications, and staying physically active, you are taking control of the condition.

Common questions in this guide

How often should I have follow-up visits and blood tests for CAD?
There is no single schedule for everyone with CAD. Stable patients may have visits about every 6 to 12 months, while symptoms, recent medication changes, kidney function, diabetes, or a recent heart event or procedure may require a different plan. Cholesterol levels are often checked 4 to 12 weeks after a medication change.
Do I need routine stress tests if my CAD symptoms have not changed?
Routine stress tests or imaging are not usually helpful for stable people who have no symptoms. They may be considered if you develop new or worsening symptoms, a decline in function, or selected high-risk features. Your clinician should decide whether testing is appropriate.
Why is taking my CAD medication consistently important?
Taking prescribed medicines as directed is associated with lower risks of death, heart attack, and hospitalization. It is also linked to fewer chest-pain episodes and better daily quality of life. Ask your care team about reminders or other adherence support if taking medicine regularly is difficult.
How do I use nitroglycerin safely for angina?
Use nitroglycerin exactly as the product label and your written angina action plan direct. Never combine nitrates with sildenafil, tadalafil, vardenafil, avanafil, or riociguat because the combination can cause dangerously low blood pressure. Tell EMS if you recently took one of these medicines.
When should I call 911 for chest pain with CAD?
Call 911 immediately if chest pain or other symptoms are new, worsening, occur at rest, or do not improve exactly as your action plan says. Do not delay emergency care by repeatedly treating persistent pain. Tell EMS about recent nitroglycerin or relevant medication use.
What are the benefits of cardiac rehabilitation after a heart event?
Cardiac rehabilitation combines supervised exercise, education, and support to help people recover and become more active. It can improve physical capacity and is linked with a lower risk of another heart attack. Supported home-based or digital programs may be as effective as center-based rehabilitation for maintaining activity.
Is anxiety or depression common after a CAD diagnosis?
Anxiety and depression are common after CAD and can be treated. Cardiac rehabilitation, psychological support, and medication may help, so share ongoing mood changes with your care team. Seek immediate help if you have thoughts of self-harm.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my individualized follow-up schedule—how often should I have blood work and office visits?
  2. 2.If my symptoms are stable, what is our plan for monitoring—will we do 'surveillance' stress tests or only test if I have new symptoms?
  3. 3.Can you provide a written, clinician-approved 'Angina Action Plan' that tells me exactly how to use my nitroglycerin and when to call 911?
  4. 4.Are there specific support groups or counseling services you recommend for managing anxiety?
  5. 5.How can I safely transition from my supervised cardiac rehab program to an independent exercise routine at home?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

    , Virani SS, Newby LK, et al.

    Journal of the American College of Cardiology 2023; (82(9)):833-955 doi:10.1016/j.jacc.2023.04.003.

    PMID: 37480922
  2. 2

    Exercise-based cardiac rehabilitation for coronary heart disease.

    Dibben G, Faulkner J, Oldridge N, et al.

    The Cochrane database of systematic reviews 2021; (11()):CD001800 doi:10.1002/14651858.CD001800.pub4.

    PMID: 34741536
  3. 3

    The impact of medication adherence on clinical outcomes of coronary artery disease: A meta-analysis.

    Du L, Cheng Z, Zhang Y, et al.

    European journal of preventive cardiology 2017; (24(9)):962-970 doi:10.1177/2047487317695628.

    PMID: 28436725
  4. 4

    Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.

    Lemesle G, Tricot O, Meurice T, et al.

    Journal of the American College of Cardiology 2017; (69(17)):2149-2156 doi:10.1016/j.jacc.2017.02.050.

    PMID: 28449776
  5. 5

    Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification, and Misinterpretation Versus Facts.

    Knowles JW, Stone NJ, Ballantyne CM

    The American journal of cardiology 2015; (116(3)):481-4.

    PMID: 26043952
  6. 6

    Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease.

    Lee JM, Kim H, Park YS, et al.

    Journal of the American College of Cardiology 2024; (83(9)):890-900 doi:10.1016/j.jacc.2023.12.027.

    PMID: 38418002
  7. 7

    From Echo to Coronary Angiography: Optimizing Ischemia Evaluation Through Multimodal Imaging.

    Babic M, Mikic L, Ristic M, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(12)) doi:10.3390/medicina61122212.

    PMID: 41470213
  8. 8

    Invasive versus Conservative Management in Coronary Artery Disease.

    Rezkalla SH, Kloner RA

    Clinical medicine & research 2023; (21(2)):95-104 doi:10.3121/cmr.2023.1806.

    PMID: 37407216
  9. 9

    Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial.

    Garcia RA, Spertus JA, Benton MC, et al.

    Journal of the American College of Cardiology 2022; (80(8)):755-765 doi:10.1016/j.jacc.2022.05.045.

    PMID: 35981820
  10. 10

    Role of short-acting nitroglycerin in the management of ischemic heart disease.

    Boden WE, Padala SK, Cabral KP, et al.

    Drug design, development and therapy 2015; (9()):4793-805 doi:10.2147/DDDT.S79116.

    PMID: 26316714
  11. 11

    Drug Therapy for Stable Angina Pectoris.

    Rousan TA, Mathew ST, Thadani U

    Drugs 2017; (77(3)):265-284 doi:10.1007/s40265-017-0691-7.

    PMID: 28120185
  12. 12

    The contribution of symptom incongruence to prehospital delay for acute myocardial infarction symptoms among Jordanian patients.

    Abed MA, Khalil AA, Moser DK

    Research in nursing & health 2015; (38(3)):213-21 doi:10.1002/nur.21658.

    PMID: 25898794
  13. 13

    Exercise-based cardiac rehabilitation for patients undergoing coronary artery operation: a systematic review and meta-analysis based on current randomized controlled trials.

    Shi Y, Xu H, Dong J

    International journal of surgery (London, England) 2025; (111(3)):2708-2721 doi:10.1097/JS9.0000000000002268.

    PMID: 39903572
  14. 14

    Impact of Cardiac Rehabilitation on Functional Capacity and Physical Activity after Coronary Revascularization: A Scientific Review.

    Prabhu NV, Maiya AG, Prabhu NS

    Cardiology research and practice 2020; (2020()):1236968 doi:10.1155/2020/1236968.

    PMID: 32274208
  15. 15

    Home-based versus centre-based cardiac rehabilitation.

    McDonagh ST, Dalal H, Moore S, et al.

    The Cochrane database of systematic reviews 2023; (10()):CD007130 doi:10.1002/14651858.CD007130.pub5.

    PMID: 37888805
  16. 16

    Home-based exercise with telemonitoring guidance in patients with coronary artery disease: Does it improve long-term physical fitness?

    Avila A, Claes J, Buys R, et al.

    European journal of preventive cardiology 2020; (27(4)):367-377 doi:10.1177/2047487319892201.

    PMID: 31787026
  17. 17

    Using path analysis to investigate the relationships between depression, anxiety, and health-related quality of life among patients with coronary artery disease.

    Lu Y, Jiang Y, Gu L

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2019; (28(10)):2695-2704 doi:10.1007/s11136-019-02207-8.

    PMID: 31098799
  18. 18

    Subgroup Differences and Determinants of Patient-Reported Mental and Physical Health in Patients With Ischemic Heart Disease: Results From the DenHeart Study.

    Rasmussen TB, Palm P, Herning M, et al.

    The Journal of cardiovascular nursing 2019; (34(4)):E11-E21 doi:10.1097/JCN.0000000000000583.

    PMID: 31135602
  19. 19

    Long-term trajectories of anxiety and depression in patients with stable coronary heart disease and risk of subsequent cardiovascular events.

    Peter RS, Meyer ML, Mons U, et al.

    Depression and anxiety 2020; (37(8)):784-792 doi:10.1002/da.23011.

    PMID: 32237189
  20. 20

    Psychological and pharmacological interventions for depression in patients with coronary artery disease.

    Tully PJ, Ang SY, Lee EJ, et al.

    The Cochrane database of systematic reviews 2021; (12()):CD008012 doi:10.1002/14651858.CD008012.pub4.

    PMID: 34910821
  21. 21

    Perceived Social Support and Physical Activity Among Patients With Coronary Artery Disease.

    Won MH, Son YJ

    Western journal of nursing research 2017; (39(12)):1606-1623 doi:10.1177/0193945916678374.

    PMID: 27881811

This page is for informational purposes only and does not constitute medical advice. Your cardiology team should personalize your CAD follow-up, medicines, nitroglycerin instructions, exercise plan, and emergency guidance.

Get notified when new evidence is published on coronary atherosclerosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.